129 related articles for article (PubMed ID: 6889585)
1. The serum levels of testosterone and prolactin in patients with prostatic carcinoma treated with various doses of Fostrolin and bromocriptin.
Jeromin L
Int Urol Nephrol; 1982; 14(1):51-6. PubMed ID: 6889585
[TBL] [Abstract][Full Text] [Related]
2. The effect of ergobromocriptine on serum testosterone and prolactin levels in patients with carcinoma of the prostate.
Taşar C; Akdaş A; Kirkali Z
Int Urol Nephrol; 1986; 18(1):71-4. PubMed ID: 2424860
[TBL] [Abstract][Full Text] [Related]
3. Testosterone metabolism in patients with advanced carcinoma of the prostate: a comparative in vivo study of the effects of oestrogen and antiprolactin.
Jacobi GH; Sinterhauf K; Kurth KH; Altwein JE
Urol Res; 1978; 6(3):159-65. PubMed ID: 758043
[TBL] [Abstract][Full Text] [Related]
4. [Hormonal environment following treatment with a small dose of estrogen--small dose of estrogen alone and in combination with an anti-androgen].
Hayashi T; Taki Y; Ikai K; Hiura M; Kiriyama T
Hinyokika Kiyo; 1987 Jul; 33(7):1035-42. PubMed ID: 2446483
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of plasma testosterone and prolactin changes in advanced cancer of prostate treated with diethylstilbestrol or estramustine phosphate.
Morales A; Nickel JC
Urology; 1985 Nov; 26(5):477-81. PubMed ID: 3904134
[TBL] [Abstract][Full Text] [Related]
6. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
Sylvester PW; Ip MM
Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of prostatic carcinoma with phostrolin and bromocriptine while monitoring serum concentrations of testosterone and prolactin].
Jeromin L
Pol Tyg Lek; 1980 Mar; 35(10):359-62. PubMed ID: 7367321
[No Abstract] [Full Text] [Related]
8. Induced hypoprolactinemia and testicular steroidogenesis in man.
Suescun MO; Scorticati C; Chiauzzi VA; Chemes HE; Rivarola MA; Calandra RS
J Androl; 1985; 6(1):10-4. PubMed ID: 3972716
[TBL] [Abstract][Full Text] [Related]
9. Effect of prolactin and the anit-prolactin bromocriptin on the testosterone uptake and metabolism in androgen-sensitive and insensitive canine organs.
Helmerich D; Altwein JE
Urol Res; 1976 Nov; 4(3):101-5. PubMed ID: 1037036
[TBL] [Abstract][Full Text] [Related]
10. [Testosterone, FSH and LH level in the serum of patients with prostatic neoplasms, treated with female hormones].
Weidner W; Krause W; Pust R; Engstfeld J; Rothauge CF
Helv Chir Acta; 1978 Jul; 45(3):287-90. PubMed ID: 701064
[TBL] [Abstract][Full Text] [Related]
11. Effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
Mackler MA; Liberti JP; Smith MJ; Prout GR
Surg Forum; 1970; 21():540-1. PubMed ID: 5535268
[No Abstract] [Full Text] [Related]
12. Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas.
Tsagarakis S; Tsiganou E; Tzavara I; Nikolou H; Thalassinos N
Clin Endocrinol (Oxf); 1995 Jun; 42(6):593-9. PubMed ID: 7634499
[TBL] [Abstract][Full Text] [Related]
13. [Effect of bromocriptine on prolactin secretion after dopaminergic receptor blockade with metoclopramide in patients with prostatic cancer treated with estrogens].
Baranowska B; Szymanowski J; Jeske W
Endokrynol Pol; 1984; 35(4):211-7. PubMed ID: 6510364
[No Abstract] [Full Text] [Related]
14. [Bromocriptine, a new therapeutic principle in prostatic adenoma and carcinoma. Basis, possibilities, limits].
Jacobi GH; Altwein JE
Dtsch Med Wochenschr; 1978 May; 103(19):827-33. PubMed ID: 77217
[No Abstract] [Full Text] [Related]
15. Effectiveness of castration versus intravenous estrogen therapy in producing rapid endocrine control of metastatic cancer of the prostate.
Maatman TJ; Gupta MK; Montie JE
J Urol; 1985 Apr; 133(4):620-1. PubMed ID: 3981712
[TBL] [Abstract][Full Text] [Related]
16. Sex hormone binding globulin binding capacity, testosterone, 5alpha-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment.
Bartsch W; Horst HJ; Becker H; Nehse G
Acta Endocrinol (Copenh); 1977 Jul; 85(3):650-64. PubMed ID: 325982
[TBL] [Abstract][Full Text] [Related]
17. Plasma testosterone in patients receiving diethylstilbestrol.
Beck PH; McAnich JW; Goebel JL; Stutzman RE
Urology; 1978 Feb; 11(2):157-60. PubMed ID: 628992
[TBL] [Abstract][Full Text] [Related]
18. Alterations of peripheral testosterone matabolism after induced hypoprolactinemia in patients with prostatic carcinoma.
Jacobi GH; Altwein JE; Hohenfellner R
Klin Wochenschr; 1979 Jan; 57(1):49-51. PubMed ID: 759717
[TBL] [Abstract][Full Text] [Related]
19. Plasma hormone levels in patients with prostatic carcinoma treated with diethylstilboestrol and estramustine.
Bishop MC; Selby C; Taylor M
Br J Urol; 1985 Oct; 57(5):542-7. PubMed ID: 3904908
[TBL] [Abstract][Full Text] [Related]
20. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]